Lipocine Inc. (LPCN)
NASDAQ·Healthcare·Biotechnology
$2.23
-3.03%
Mkt Cap $43.75M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$15.00
Range $15.00 – $15.00
Implied Upside
+574.2%
Consensus $15.00 vs current $2.23
NASDAQ·Healthcare·Biotechnology
$2.23
-3.03%
Mkt Cap $43.75M
No recent rating data.
Price Target (2 analysts)
$15.00
Range $15.00 – $15.00
+574.2%
Consensus $15.00 vs current $2.23